-
Recent Posts
- Lanham Act requires less in the way of injury from competitors than California FAL/UCL
- high sugar content doesn’t make “Breakfast Essentials” name or health claims misleading
- plaintiff can use UCL against healer claiming advanced degrees and magical powers
- unauthorized sales of books as “new” don’t violate the Lanham Act, even with default
- “toddler drink” plausibly misleads about suitability as next stage after infant formula
Recent Comments
Archives
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- June 2013
Categories
- 230
- acpa
- advertising
- antitrust
- art law
- attribution
- blogging
- california
- cfaa
- cfps
- class actions
- cmi
- comics
- commercial speech
- conferences
- consumer protection
- contracts
- copying
- copyright
- counterfeiting
- cultural property
- damages
- dastar
- defamation
- design patent
- dilution
- disclosures
- disparagement
- dmca
- drm
- fan fiction
- fanworks
- fda
- fees
- first amendment
- ftc
- geographic indications
- http://schemas.google.com/blogger/2008/kind#post
- insurance
- jurisdiction
- libraries
- misappropriation
- music
- my lawsuits
- my writings
- parody
- patent
- patents
- preemption
- presentations
- privacy
- procedure
- reading list
- remedies
- right of publicity
- secondary liability
- securities
- standing
- surveys
- teaching
- tortious interference
- trade secrets
- trademark
- traditional knowledge
- Uncategorized
- unconscionability
- unfairness
- warranties
Meta
mortgages and the UCL: an occasional series
Pestana v. Bank of America, 2014 WL 2616840, No. A137566 (Cal. Ct. App. June 12, 2014)
Pestana sued his mortgage loan servicers (BoA) after BoA denied his application for a loan modification under the federal Home Affordable Mortgage Program (HAMP), and instead offered him an allegedly less favorable in-house modification, which he accepted. He alleged that BoA representatives made misrepresentations about the requirements and availability of a HAMP modification, breached promises to modify his loan, improperly stalled the modification review process, and incorrectly denied his application for a HAMP modification. The trial court dismissed all his claims, but the court of appeals revived his UCL claim.
The breach of an oral agreement claim was dismissed because there was no writing signed by BoA, despite the alleged oral promise to review Pestana’s application/modify his loan. The only letter he received just listed documents he should send in and didn’t make promises.
The promissory estoppel claim relied on oral statements made by BoA representatives during three telephone conversations, but none of these was enough to make a clear and unambiguous promise supporting a claim for promissory estoppel. Pestana first alleged that a BoA representative named Bob told him that, if he became delinquent on his mortgage payments, he would receive a loan modification. But he didn’t allege that Bob promised a HAMP modification, and he alleged that he only learned about HAMP later. Offering an in-house modification fulfilled any general promise of a modification. Then, Pestana alleged that a BoA rep named Denise told him he’d be evaluated for a HAMP modification if he returned the appropriate form and supporting documentation, and that this implied that BoA’s evaluation would be conducted in good faith. But this too was not a clear and unambiguous promise that BoA would conduct its evaluation in a particular manner. And BoA fulfilled its general promise to evaluate Pestana’s application, ultimately rejecting it. Finally, Pestana alleged that a rep named Shawn told him that BoA had received all the required documentation and that the review process would begin immediately, which he alleged implied good faith review. The court found no express promise about how the review would be conducted.
Intentional misrepresentation claims were also dismissed. They’re a variety of fraud claims. The allegations didn’t establish that the reps made false promises or promises without any intention of performing them. Requests by BoA for additional documentation and BoA’s denial of his application didn’t themselves involve false representations or false promises, except for (allegedly) BoA’s statement that Pestana didn’t qualify for a HAMP modification, and Pestana didn’t believe or rely on that.
However, the UCL claim was different. BoA allegedly
(1) told borrowers, including Pestana, that, if (and only if) they stopped making mortgage payments, they could apply for loan modifications and Bank would review their applications in good faith, (2) promised Pestana he would be granted a modification, (3) stalled the review process for Pestana and other borrowers, including by requesting documents Bank had already received, and (4) falsely represented to qualified borrowers, including Pestana, that they did not qualify for HAMP modifications.
BoA argued that Pestana lacked standing. But Pestana alleged that he incurred late fees and penalties after he stopped making (and continued to withhold) his mortgage payments in reliance on BoA’s representations about the availability and requirements of a loan modification. That was enough to show economic injury and causation at this stage. Pestana alleged that he stopped making mortgate payments “after (and in reliance on) representations in June 2009 by a [BoA] representative that (1) [BoA] could not help him with a loan modification as long as he was current on his payments, and (2) if he were to miss his payments, he would receive a modification.” His default and late fees could thus be traced to BoA.
BoA argued that Pestana was contractually obligated to pay late fees if he missed mortgage payments and thus couldn’t count them as injury. Even if the note so provided, that didn’t mean Pestana suffered no economic injury: he wouldn’t have become obligated to pay the late fees if he hadn’t stopped paying. BoA also argued that Pestana ultimately received an in-house loan modification, but at the pleading stage the court wasn’t going to determine the factual question of whether this was enough benefit to match or outweigh his loss.
UCL “fraudulent” conduct: This doesn’t require the elements of the common-law tort of fraud, but rather only requires a showing that members of the public are likely to be deceived. Pestana sufficiently alleged that BoA made untrue or misleading representations that were likely to deceive reasonable consumers, such as that modifications would only be possible if he stopped making mortgage payments. Then BoA allegedly stalled the review process, racking up extra late fees and penalties that benefited BoA as servicer. And BoA allegedly falsely told Pestana and other borrowers they did not meet the eligibility requirements for HAMP modifications. At the demurrer stage, the court couldn’t determine that BoA’s statements were accurate and nonmisleading.
Clean-up: the absence of a federal right of action under HAMP didn’t bar the UCL claim. There was no indication that federal law displaced state remedies.
Posted in california, consumer protection, unfairness
Leave a comment
A little more than kin: prominent house mark overcomes weak evidence of confusion
KIND LLC v. Clif Bar & Co., 2014 WL 2619817, No. 14 Civ. 770 (S.D.N.Y. June 12, 2014)
KIND sought a preliminary injunction against Clif Bar’s new trade dress for its MOJO bars; the court denied the motion. KIND defines its trade dress as
(1) packaging with a transparent, rectangular front panel revealing a large portion of the bar itself; (2) a horizontal stripe bisecting the transparent front panel containing the flavor of the bar in text; (3) a text description of the product line (e.g. “Fruit & Nut,” “Plus,” or “Nuts & Spices”) in line with the horizontal stripe bisecting the transparent front panel; (4) a vertical black band, offset to the side of the package, containing a bulleted list of many of the bar’s key healthful attributes; (5) opaque vertical bands, or end caps, at either edge of the product package; and (6) a 40g size, in a slender shape.
![]() |
| KIND bar |
KIND also sought to protect “the overall impression of the packaging,” not just those six specific elements, but the court wasn’t having it. A clear definition of the protectable dress is necessary to allow courts and defendants to know what they’re supposed to be evaluating, and to avoid protecting a look at an improper level of generality.
First, the court determined that the trade dress was neither inherently distinctive nor generic. Distinctiveness should be evaluated bearing in mind (1) the risk that overextension of trade dress protection could undermine limits on copyright and patent law, and (2) that trade dress doesn’t protect an idea, a concept, or a generalized type of appearance. KIND understandably cited the old Landscapelanguage that “the varieties of labels and packaging available to wholesalers and manufacturers are virtually unlimited [so] a product’s trade dress typically will be arbitrary or fanciful and meet the inherently distinctive requirement for § 43(a) protection.” But KIND’s own “very common packaging design” wasn’t inherently distinctive. Nor was it generic—the combination of the six elements wasn’t a “singular custom in the industry.”
Running through the evidence, many food bars use one or more of the six elements KIND sought to protect: transparent packaging, horizontal banners with product/flavor descriptions, product attributes along one side of front panel, 40 gram size, and opaque end caps. Many of these were also common in the food industry in general. Most of these elements also served functional purposes—the transparent window reveals the bar within; the text description informs consumers of the bar’s ingredients, etc.—and this also weighed against finding the trade dress protectable. These elements, either individually or together, just didn’t identify source. The KIND logo wasn’t included in the claimed trade dress. (And its two registrations for its packaging differed from that claimed here, most notably by including “KIND.”) All the elements it sought to protect here instead described its product, particularly the most prominent feature: the transparent, rectangular front panel. Likewise the text description and the 40g size in a “slender shape”; the horizontal stripe bisecting the transparent front panel contained the flavor, and the vertical black band contained “a bulleted list of many of the bar’s key healthful attributes.” The opaque end caps might not seem descriptive at first, but they sometimes reflected the bar’s flavor or featured plus signs to show that the bar was part of KIND’s “Plus” line.
So, could KIND show secondary meaning? Relevant factors: (1) advertising expenditures, (2) consumer studies linking the dress to the source, (3) unsolicited media coverage of the product, (4) sales success, (5) attempts to plagiarize the dress, and (6) length and exclusivity of the trade dress’s use. KIND failed to meet its heavy burden of showing secondary meaning.
![]() |
| MOJO bar |
The court found evidence that Clif Bar did deliberately copy elements of the KIND trade dress, making factor (5) favor KIND. Sample statements: an email recapping a MOJO redesign meeting stated that “[e]veryone also agreed that Kind is a best in class packaging that we should learn from for MOJO,” with a “[l]arge product visual with clear window”; “[g]ood branding (KIND)” (although that wasn’t part of the trade dress at issue here); “[c]laims on front panel (not wrapped); and “[g]ood flavor communication claim.” Another internal document said that KIND had an “advantage” in packaging because of its “large clear window” and because its “claims are clearly indicated on the front wrapper”; an email instructed a team member to “[b]ring multiple KIND bars” to a MOJO redesign meeting; a presentation indicated that one “packaging objective[ ]” was to “[c]ompete head-to-head with Kind” by incorporating a “[l]arger window to showcase bar with whole pieces of fruits & nuts,” a “[s]imilar window shape & coloring to Kind.” At one point a brand manager said that the MOJO packaging was “now too close to KIND.”
That wasn’t enough to show secondary meaning, though. Since launch, KIND had spent more than $100 million on marketing and advertising, had sold $600 million dollars’ worth of KIND bars, had received extensive unsolicited media coverage, and all KIND bars allegedly shared the six elements at issue. However, KIND didn’t show that these sales/ads/etc. resulted in consumers associating these six elements with KIND, in the absence of the logo. Even four ads featuring KIND bars without the logo displayed the logo elsewhere on the ad. Thus, the court couldn’t determine whether secondary meaning existed in these elements, or the logo, or the logo plus the six elements.
While “intentional copying constitutes persuasive evidence of consumer recognition, conscious replication alone does not establish secondary meaning.” (Otherwise competitors would hesitate to copy good, descriptive ideas.)
Though it wasn’t necessary, the court ran through the confusion factors as well.
Strength of the trade dress: the court found it to be weak—descriptive, and without secondary meaning. The commercial context also mattered: many food bars used the six elements, either individually or some in combination, which additionally undercut the strength of the trade dress and “indicate[d] that its claim is pitched at an improper level of generality.” KIND’s CEO even testifed that the Think Thin Crunch bar “may arguably be infringing” as well, but most of the six elements at issue didn’t appear on its trade dress—the only similarities were the transparent window and the opaque end caps. This was impermissibly seeking protection for “a generalized type of appearance.”
Similarity: Though the trade dresses shared some similar elements, the overall impression differed significantly, weighing against KIND. KIND’s witness explained that packaging can be divided into two types, one that emphasizes straight lines and minimizes curvature, and the other that has or emphasizes curvature. Jargon ahoy: KIND’s trade dress is best described as “minimalist,” “simple,” “clean,” “modern,” and “sleek,” connecting with its brand concepts of integrity and simplicity. It uses straight lines. The MOJO trade dress has a different color scheme, fonts, and number and placement of design elements; it’s embellished rather than minimalist; and it uses curves in the large curved “J” of MOJO, the cursive font used to describe the product-line, and the mountain displayed along the bottom of the packaging. Its movement/mountain imagery “connects with the core concepts” of the Clif Bar/MOJO brands.
Also, the prominent use of MOJO and the Clif Bar mark, which has 87% aided awareness, tended to dispel any confusion. See Bristol-Myers Squibb Co. v. McNeil-P.P.C., Inc., 973 F.2d 1033, 1046 (2d Cir. 1992) (house brands can prevent confusion). KIND argued that the Bristol-Myers rule didn’t apply because the Clif marks weren’t prominent enough and weren’t universally recognized, and because the KIND trade dress was remembered better than the name. The court disagreed: the marks didn’t have to be the most prominent part of the trade dress to dispel confusion, and anyway MOJO was the second most prominent feature after the transparent window. Also, the evidence didn’t show general consumer recognition of KIND bars only through the six claimed elements.
Competitive proximity favored KIND; there was no gap to bridge.
Actual confusion evidence was weak; its absence wouldn’t weigh against KIND because the product was new to the market. This factor weighed slightly in KIND’s favor: There were dueling surveys and some anecdotal evidence.
KIND’s survey found 15% net confusion. This was “on the lower end of rates that courts within this Circuit have found sufficient to show actual confusion.” True, in the bad old days some courts accepted gross rates of 15% without control groups, but that was before courts understood consumer survey evidence.
Plus, Clif Bars’ expert credibly testified that the KIND survey was flawed because it only measured whether there was confusion, not what caused it. When there is a multi-element trade dress, it’s vital to understand what causes the problem. But the control had none of the elements. Thus, the survey may have underestimated noise/overestimated confusion. The survey respondents were asked: “Do you think this brand of [snack bars] is or is not made by or made with the approval or sponsorship of the same company that makes the [corresponding type of product] you saw in the earlier photo?” Yes-sayers got follow-ups, and the verbatim responses to “What makes you say that?” and “Anything else?” questions proved Clif Bars’ point. Some responses cited the similar packaging; other responses cited the similar flavors of the KIND and MOJO bars (e.g., “They have the same flavors, and are both healthy snack bars”; “Fruit and nut was on most of the packaging with the exception of the chocolate bar I believe. Looks like a higher quality of the same bars”; “They had the exact same titles for each of the different bars”); others cited both packaging and flavors; and others just completely whiffed (e.g., “These are very nice packages and I was looking for a special Valentine gift along these lines anyway, so it is exciting to encounter new products with better ingredients”; “I think this would be in every store and people would love to buy them.”). Thus, the court gave little weight to the survey.
The anecdotal evidence of confusion involved one customer who thought the MOJO bar he’d selected was a KIND bar, but he had “no clue” about the bar he selected, and told the interviewer he was looking for a KIND bar because his daughter told him to buy it. Since “the correct test is whether a consumer who is somewhat familiar with the plaintiff’s [dress] would likely be confused when presented with defendant’s [dress] alone,” this didn’t matter. Another potential consumer who shared an apartment with a KIND employee, selected a MOJO bar, believing it to be a KIND bar, from a bowl of snacks in her apartment. But this confusion might have resulted from her expectation that she’d find KIND bars in her home because of her roommate’s employment. That wasn’t probative of the average consumer in marketplace conditions.
KIND also relied on social media post, but the court found them “mostly unhelpful.” Comments on Clif Bar’s Facebook posts noted similarities between the bars, e.g., “I love all things Clif and I’m sure I’ll like these too, but don’t they kinda look like Kind bars?” But assertions of similarity don’t establish confusion. One tweet said, “I was about to pick up one of those [MOJO bars] because I thought it was a Kind Bar at the vitamin shop ….,” and that did suggest actionable initial interest confusion. (Argh! Confusion remedied before the consumer even takes physical action should not count. That’s just initial attention. There are no sunk costs making this like bait and switch.) But the overall evidence of actual confusion was weak.
Bad faith: the evidence didn’t show an intent to deceive consumers into believing that the MOJO bar was made or sponsored by KIND, and thus this factor weighed in favor of Clif Bar. Intent to compete by imitating is vastly different from an intent to deceive. The prominent display of the MOJO/Clif Bar marks and dissimilarity to KIND’s minimalist trade dress negated any inference of intent to deceive.
Quality: no evidence; no one cares.
Buyer sophistication: About half of retail outlets sell KIND bars in a “primarily impulse” setting, but over three-quarters of its sales volume comes from frequent purchasers who eat a bar several times a week or more. Some buyers are casual and some careful. The court gave this factor little weight.
The court also identified other marketplace factors that favored Clif Bar. Here, the “caddies” or “inner cases” in which these products are often sold, and the point of sale displays Clif Bar has provided retailers, all prominently bore the MOJO and Clif marks, thus dispelling confusion. In addition, many MOJO and Clif bars are sold through mass market and grocery stores, where MOJO bars are often grouped with other Clif Bar products and KIND bars are often grouped with other KIND products.
Balancing the factors, no confusion was likely. Thus there was no irreparable harm.
Under the alternate standard for preliminary relief (assuming it survives eBay), KIND also failed. Clif Bar alleged sunk costs for the new MOJO products of $13.9 million, including inventory ready to ship and already shipped; “contracted ingredient and marketing commitments; R & D development costs; the cost of sales kits, merchandising shippers, plan-o-grams and reset work; and the forecasted loss of sales from Clif Bar products discontinued to make room for new CLIF MOJO products on the shelf.” KIND’s proposal for a three-month sell-off period would reduce losses only as to the first category. It would cost Clif Bar approximately $500,000 and take eight months to develop and manufacture new packaging, with a loss of $10 million in revenue during that period, with consequent harm to brand loyalty and reputation while it couldn’t fulfill its commitments. While KIND argued that ingredients could be repurposed and that a new design would only take three months, KIND’s irreparable harm was premised on KIND’s alleged loss of goodwill and market share through confusion, which wasn’t sufficiently shown, so it couldn’t meet its burden of showing that the balance of harms tipped decidedly in its favor.
Posted in surveys, trademark
Leave a comment
POM Won: a summary of the ruling
POM Wonderful LLC v. Coca-Cola Co., No. 12–761, 573 U.S. — (June 12, 2014)
POM sued Coca-Cola for falsely advertising a “pomegranate blueberry” juice blend with 0.3% pomegranate juice and 0.2% blueberry juice. The Ninth Circuit found this claim precluded by the FDA’s extensive juice labeling regulations, and the Supreme Court reversed in a broad opinion that nonetheless leaves room for preclusion arguments, certainly in pharmaceutical cases. Examining text, history, and structure of both laws showed no congressional purpose to forbid private suits in cases of this type, but the Court left room to fight about just what POM’s “type” is. (E.g., does this ruling have any bearing at all on a case in which at least part of the plaintiff’s evidence of falsity is use of a term that is inconsistent with a FDA definition thereof, such as “generic”? Consider in this regard what the Court says below about the FDA’s area of expertise ….)
We know that Congress, in the Lanham Act, intended to protect competitors from deceptive advertising/unfair competition. (The Court uses “competitor” as a shorthand for people with standing under Lexmark.)
The FDCA “is designed primarily to protect the health and safety of the public at large.” It prohibits misbranding of food and drink, which includes false or misleading labeling. The FDA promulgated extensive regulations about juice labeling to implement this mandate. Under these regulations, “[i]f a juice blend does not name all the juices it contains and mentions only juices that are not predominant in the blend, then it must either declare the percentage content of the named juice or ‘[i]ndicate that the named juice is present as a flavor or flavoring,’ e.g., ‘raspberry and cranberry flavored juice drink.’” The FDA does not preapprove juice labels, unlike drug labels, “consistent with the less extensive role the FDA plays in the regulation of food than in the regulation of drugs.” The FDCA may not be privately enforced, and the NLEA preempted many non-identical requirements from a state or political subdivision of a state.
![]() |
| Minute Maid Pomegranate Blueberry … |
“Despite the minuscule amount of pomegranate and blueberry juices in the blend,” “pomegranate blueberry” is prominent and set-off on the label, with “flavored blend of 5 juices” in much smaller type, then “from concentrate with added ingredients,” in still smaller type, then “and other natural flavors.” There’s also a vignette of blueberries, grapes, and raspberries in front of a halved pomegranate and a halved apple. The Ninth Circuit held that the FDA’s extensive regulation precluded a Lanham Act claim against these elements.
The court began by distinguishing preemption, which involves a state-federal balance and a resulting presumption against preemption. Nonetheless, preemption principles were instructive “insofar as they are designed to assess the interaction of laws that bear on the same subject.”
But at the core, this was a statutory interpretation case. POM argued that two statutes must be given full effect unless they are in “irreconcilable conflict.” Coca-Cola argued that a more specific law, the FDCA, narrowed the scope of a more general law, the Lanham Act. Even if the Court’s task were to reconcile the two laws, Coca-Cola was wrong that the best way to harmonize them was to bar the Lanham Act claim.
The Lanham Act, by its own terms, has a “comprehensive imposition of liability” extending to food and beverage labels. And the FDCA, by its own terms, doesn’t bar Lanham Act suits. The absence of textual preclusion is especially significant because the Lanham Act and the FDCA have coexisted since the passage of the Lanham Act in 1946. Congress has amended both during the last 70 years, and could’ve addressed interference by the Lanham Act with the FDA if it had concluded that there was any, for example when it enacted the express preemption provision in the NLEA. “This is ‘powerful evidence that Congress did not intend FDA oversight to be the exclusive means’ of ensuring proper food and beverage labeling.” If anything, applying expressio unis to the NLEA suggests that Lanham Act suits are not precluded:
It is significant that the complex pre-emption provision distinguishes among different FDCA requirements. It forbids state-law requirements that are of the type but not identical to only certain FDCA provisions with respect to food and beverage labeling. Just as significant, the provision does not refer to requirements imposed by other sources of law, such as federal statutes…. By taking care to mandate express pre-emption of some state laws, Congress if anything indicated it did not intend the FDCA to preclude requirements arising from other sources.
Structure reinforced text. “When two statutes complement each other, it would show disregard for the congressional design to hold that Congress nonetheless intended one federal statute to preclude the operation of the other.” So here: each statute has its own scope and purpose. “[T]he Lanham Act protects commercial interests against unfair competition, while the FDCA protects public health and safety.” They complement each other more fundamentally, in that the FDA is largely responsible for enforcing the FDCA, but it doesn’t have “the same perspective or expertise in assessing market dynamics that day-to-day competitors possess.” Those competitors have detailed knowledge about consumer reaction to “certain sales and marketing strategies,” and “[t]heir awareness of unfair competition practices may be far more immediate and accurate than that of agency rulemakers and regulators.” The Lanham Act allows this market expertise to be brought to bear on a case-by-case basis. By providing compensation that may motivate injured parties to come forward, the Lanham Act provides additional incentives for manufacturers to behave well. Allowing Lanham Act suits “takes advantage of synergies among multiple methods of regulation.” Each statute thus has its own mechanisms to enhance the protection of competitors and consumers.
(As I wondered after oral argument, I wonder how this conclusion about competitor expertise plays out in First Amendment challenges to FDA regulations. There’s room here, especially given the Court’s reference to “synergies,” to argue that the FDA may underidentify misleading behavior, but still has expertise to determine a minimum blanket rule for what’s false/misleading—but I worry the DC Circuit won’t go for that.)
A preclusion finding for food and beverage labels would cut a hole in consumer protection. The FDA doesn’t preapprove such labels, as it does for drugs, and the FDA acknowledges that it doesn’t pursue enforcement against all objectionable labels. If Lanham Act claims weren’t allowed, then competitors, and indirectly the public, “could be left with less effective protection in the food and beverage labeling realm than in many other, less regulated industries. It is unlikely that Congress intended the FDCA’s protection of health and safety to result in less policing of misleading food and beverage labels than in competitive markets for other products.”
Coca-Cola argued that preclusion was appropriate because Congress wanted national uniformity in food and beverage labeling. But that desire wasn’t enough. Congress did delegate FDCA enforcement to the feds, but POM wasn’t trying to enforce the FDCA. Preemption of a possible patchwork of state standards was different:
Although the application of a federal statute such as the Lanham Act by judges and juries in courts throughout the country may give rise to some variation in outcome, this is the means Congress chose to enforce a national policy to ensure fair competition. It is quite different from the disuniformity that would arise from the multitude of state laws, state regulations, state administrative agency rulings, and state-court decisions that are partially forbidden by the FDCA’s pre-emption provision.
Congress often allows variability “even in areas of law where national uniformity is important.” (Citing Bonito Boats’ statement about the importance of national uniformity in IP, then noting the private right of action for patent infringement, and noting that the FDCA contemplates that federal juries will resolve most misbranding claims.) The Lanham Act is uniform in the sense that it protects an entire class against unfair competition; it varies only in being enforced on a case-by-case basis. That’s no different than the variability to which any industry is subject.
Coca-Cola argued that the FDCA regulations were much more specific than the Lanham Act. That’s true. But that specificity would matter “only if the Lanham Act and the FDCA cannot be implemented in full at the same time.” However, there was no structural or empirical reason to see “any difficulty in fully enforcing each statute according to its terms.”
The Court then rejected the government’s confusing halfway approach, which wouldn’t have allowed POM to challenge the name but would have allowed other challenges to the configuration of the label. The government wanted preclusion “to the extent the FDCA or FDA regulations specifically require or authorize the challenged aspects of [the] label.” The Court was concerned about the practical difficulty of distinguishing between regulations that “specifically . . . authorize” a course of conduct and those that merely tolerate that course. Also, this position had the same problem of treating the FDCA as a ceiling on regulation of food and beverage labeling, but that was inconsistent with the Lanham Act’s complementarity. (It’s pretty clear that requirements would not be subject to this analysis—if someone challenged a label that said “zero fat” even though it had a tiny detectable amount of fat, the obvious defense is that the FDA requires the use of “zero fat” under such circumstances, and the Court doesn’t suggest that preclusion would be unavailable then.)
The FDA had not, despite what the government said, fully balanced the competing interests at issue. While the rule mentioned “provid[ing] manufacturers with flexibility for labeling products while providing consumers with information that they need,” it didn’t discuss or even cite the Lanham Act. Plus, the FDA explicitly encouraged manufacturers to include material on labels that wasn’t required by the regulations, which was inconsistent with the idea that the regulations were comprehensive. “A single isolated reference to a desire for flexibility is not sufficient to transform a rulemaking that is otherwise at best inconclusive as to its interaction with other federal laws into one with preclusive force, even on the assumption that a federal regulation in some instances might preclude application of a federal statute.”
This was distinguishable from Geier v. American Honda Motor Co., 529 U. S. 861 (2000), in which the agency’s regulation deliberately allowed manufacturers to choose between options to encourage diversity in the industry. A subsequent lawsuit against one of the choices was barred because it directly conflicted with the agency’s policy choice. But the FDA hadn’t made a policy judgment inconsistent with POM’s suit, “and in any event the FDA does not have authority to enforce the Lanham Act.” “Even if agency regulations with the force of law that purport to bar other legal remedies may do so, it is a bridge too far to accept an agency’s after-the-fact statement to justify that result here. An agency may not reorder federal statutory rights without congressional authorization.”
Reversed and remanded.
Final note: because the 9th Circuit’s ruling was so broad and ill-defined, and because the Court is careful to distinguish pharmaceutical regulation, it’s hard to say that this will directly affect many lawsuits, though plaintiffs may draw on the Court’s emphasis on the Lanham Act’s breadth.
The Pom Wonderful ruling has arrived
It is here. Pom wins reversal. More to come.
selling to multiple hospitals isn’t "advertising or promotion" when total market is large
Synthes, Inc. v. Emerge Medical, Inc., 2014 WL 2579286, — F. Supp. 2d — (E.D. Pa. June 5, 2014)
This is a big case involving trade secrets/former employees who started a competing medical device firm. I’m just going to cover a few bits. The Lanham Act false advertising claim, which included challenges to Emerge’s comparative statements about the Synthes product, seem headed towards failure because the statements weren’t sufficiently disseminated to count as advertising or promotion. (Post edited for clarity: Given the procedural posture–a denial of summary judgment for the plaintiffs on their Lanham Act claim–all that can be said right now is that the court didn’t need to resolve any other issue to deny summary judgment to Synthes.)
At one point, Emerge “would begin the sales process by approaching a hospital system directly—either by phone, email or in person, through corporate supply chain management. Emerge would then describe its method of not relying on sales reps and would make representations about the characteristics and performance of its products. These statements were made via phone calls, emails, in-person meetings, websites, printed materials, presentations, trade show displays, and social media.”
Even if the statements were literally false, discovery had shown only sporadic instances of dissemination. The identified recipients included 9 healthcare facilities/groups and several other hospitals in the Arizona, Texas, Massachusetts, Georgia, and California regions. However, the relevant device market was national since each hospital and orthopedic surgeon was a potential customer. Thus, this didn’t show wide dissemination throughout the relevant market. (How close does “sufficiently disseminated” have to be to “nationally/nearly comprehensively”? A campaign that reaches 25% of a huge market can do a lot of harm, and the description of the conduct seems to me to cross over from sporadic to a significant component of a marketing strategy, even if not the only component.)
The CFAA claim was dismissed for failure to show sufficient harm. Synthes argued that it incurred sufficient expenses in investigating the data breach at issue to trigger the CFAA, but there’s a difference between the harm caused by the misappropriation of data/expenses incurred in litigating the issue and the requisite CFAA harm caused by investigating damage to the integrity of a computer system. Synthes’ evidence went to the former. Synthes only investigated damage to its systems once the litigation began, over a year after the alleged unlawful access.
animal rights organizations have standing to challenge bull run
Animal Legal Defense Fund v. Great Bull Run, LLC, 2014 WL 2568685, No. 14–cv–01171 (N.D. Cal. June 6, 2014)
ALDF and PETA sued defendants under California’s UCL to enjoin them from operating a bull run. The court denied the motion to dismiss for lack of standing.
Plaintiffs alleged that Great Bull Run organizes events in which “panicked and agitated bulls chase down fleeing runners,” while defendant Lone Star Rodeo supplies bulls and steers for the events, transporting them thousands of miles in trailers. According to plaintiffs, the events involve
people on horses using ropes as whips to scare as many as three dozen bulls—each of which weighs approximately 1,500 pounds—to charge towards as many as 1,000 people arrayed along a quarter-mile track. As the bulls approach at speeds faster than humans can run, the participants try to keep up while avoiding the stampede at their heels. Many runners intentionally run as close to the bulls as possible to provoke them. An eyewitness at the most recent bull run event in Florida reported that several runners taunted and punched the bulls as they ran by.
Plaintiffs alleged that these events subjected bulls to needless suffering, distress, and unnecessary cruelty. Bull runs are allegedy dangerous for the animals because bulls “may become entangled with other bulls or runners, causing them to slip and break their legs or get gored.” They are also inherently stressful to the bulls, “who find themselves in an unfamiliar location surrounded by loud noises, often after having travelled for days in cramped transport trailers.” GBR and Lone Star allegedly take advantage of this fear and confusion to motivate the animals to stampede.
Moreover, bull runs are allegedly dangerous for humans; three participants in prior events were trampled and hospitalized. GBR’s emergency plan still allegedly provides that if someone is injured on the track, the bulls will still be released and no medical personnel will be allowed to enter the course area. GBR requires contestants to sign a waiver form acknowledging that the event is hazardous and presents serious physical and mental dangers.
ALDF alleged that it has invested time and money to prevent these events, “committing staff time and resources to educating the public about the animal welfare concerns, mobilizing opposition such as petition drives, researching permitting requirements, submitting public records requests to local governments, reviewing responsive documents, and speaking with state agencies and local officials about the event.” PETA made similar allegations.
According to plaintiffs, defendants were unlawfully “‘promot[ing] [and] advertis[ing] [a] … bloodless bullfight contest or exhibition, or … similar contest or exhibition,’ in violation of section 597m of the California Penal Code. In addition, the bull run would violate 597b, which prohibits making bulls fight with humans, and section 597(b), which prohibits causing ‘needless suffering’ to animals.”
Defendants argued that plaintiffs lacked an injury in fact. But “[a]n organization suing on its own behalf can establish an injury when it suffered ‘both a diversion of its resources and a frustration of its mission.’” This was sufficiently alleged. Redirected resources/staff time investigating defendants’ practices wouldn’t be necessary but for defendants’ actions, and plaintiffs diverted these resources not just in response to defendants’ activities “but also to counteract the effect these events have on Plaintiffs’ own outreach and education efforts designed to prevent animal cruelty.” Taken as true, these allegations were enough to plead that defendants’ acts perceptibly impaired plaintiffs’ outreach and education efforts by diverting resources to fight defendants’ allegedly unlawful acts. Although this diversion resulted from a voluntary choice, that’s not dispositive. What matters is “whether they undertook the expenditures in response to, and to counteract, the effects of the defendants’ alleged [unlawful acts] rather than in anticipation of litigation.” Defendants argued that plaintiffs were just trying to set up this litigation, but that’s not what the complaint alleged.
What about UCL standing? Did plaintiffs lose money or property? They alleged that they spent money and organizational resources to send agents to witness and record the GBR in other states, and also spent staff time requesting and reviewing public records, incurring costs in both money and payroll expenses. This was enough: “Organizational plaintiffs have standing under the UCL where they divert resources as a result of a defendant’s alleged unlawful business practices.”
Did plaintiffs state a valid claim? Defendants argued that there was no private right of action to enforce the California Penal Code, and that it was improper to use the UCL to circumvent this restriction. The first part is true, but the second isn’t. The UCL provides for a private cause of action for “unlawful” acts, which is to say violations of other laws. It is a “sweeping,” “intentionally broad” borrowing provision. The limitation is that a plaintiff can’t plead around an absolute bar to relief, as when another rule or law provides immunity for particular conduct. (E.g., conduct subject to a litigation privilege.) But the animal cruelty laws don’t have any immunity or absolute privilege of that sort.
Posted in california, standing
Leave a comment
No nominative fair use or dilution dismissals if plaintiff pleads the elements?
Valley Forge Military Academy Found. v. Valley Forge Old Guard, Inc., No. 09–2373, 2014 WL 2476115 (E.D. Pa. Jun. 2, 2014)
Nominative fair use doesn’t have to work this badly, guys!
Valley Forge Military Academy Foundation operates the Valley Forge Military Academy, a college-prep boarding school and a two-year college. The Foundation and coplaintiff Valley Forge Military Academy and College Alumni Association alleged that they own/license various federally registered and common law marks, including “Valley Forge Military Academy,” “Valley Forge Military Academy & College Alumni Association,” and “Valley Forge Experience.” The Foundation also alleged goodwill in marks such as “Lieutenant General Milton G. Baker Founder’s Society,” “Baker Founder’s Society,” and “Founder’s Society.”
Valley Forge Old Guard is a nonprofit that has criticized plaintiffs over the past few years. Plaintiffs alleged that Old Guard used their marks to solicit funds from parents and alumni. Plaintiffs submitted two letters from parents of students at the Academy allegedly showing actual confusion about the distinction between the Old Guard and the Alumni Association. The Alumni Association’s mission statement reads: “[T]o enhance the quality of the ‘Valley Forge Experience’ and to contribute to the welfare and future of the finest institution of its kind in the world through leadership, recognition, contribution of resources, and the investment of time.” The Old Guard’s mission statement reads: “[T]o enhance the nature of the ‘Valley Forge Experience’ by contributing to the welfare, viability, and future of the Valley Forge Military Academy and College and its Corps of Cadets through leadership, the investment of time, the proper management of tangible resources ….”
After a C&D, the Old Guard changed its name from the Valley Forge Old Guard to the Founder’s Old Guard, and changed its website from http://www.valleyforgeoldguard.org to http://www.foundersoldguard.org, adding a disclaimer that disavowed any affiliation between the Old Guard and the Alumni Association. Plaintiffs were unsatisfied, and contested the use of “Founder’s” in the new name. They sued for trademark infringement, false advertising, and dilution.
The court rejected defendants’ arguments that their speech wasn’t commercial. The court first quoted the general standard for commercial speech: basically, is it an ad for a product/service by someone with an economic motivation for the speech—is it speech proposing a commercial transaction? But it quickly pivoted to the more expansive definition used in Lanham Act cases. (Cf. Riley v. Nat’l Fed’n of the Blind, finding fundraising speech for nonprofits to be noncommercial.)
Plaintiffs alleged that defendants competed with the Alumni Association for fundraising and alumni services, and that they used plaintiffs’ marks in an ad referring to a specific service: the Old Guard emailed 4000 people promoting the Old Guard’s alumni services, with an economic motivation—they solicited funds. This plausibly alleged that the Old Guard proposed a commercial transaction, not another type of speech. Thus, their “appropriation of Plaintiffs’ marks for commercial purposes” was not protected by the First Amendment.
Unsurprisingly, the court then rejected defendants’ arguments that they weren’t using plaintiffs’ marks to sell goods or services. “Services” is a broad term that has been applied to lots of defendants providing noncommercial public/civic benefits. United We Stand Am., Inc. v. United We Stand, Am. N.Y., Inc., 128 F.3d 86, 89 (2d Cir. 1997); Villanova Univ. v. Villanova Alumni Educ. Found., Inc., 123 F. Supp. 2d 293, 306 (E.D.Pa. 2000) (applying Lanham Act to alumni organization and finding that while “they are not commercial entities, the parties to this action are now in competition in that they offer similar services and engage in similar activities”); Am. Diabetes Ass’n, Inc. v. Nat. Diabetes Ass’n., 533 F. Supp. 16, 20 (E.D. Pa.1981) (applying Lanham Act to two organizations that solicit donations to find services for diabetics). The services here were provided to the Academy’s alumni.
Likely confusion: defendants argued that their messages criticized plaintiffs, and thus couldn’t be confusing. But plaintiffs alleged that defendants were their competitors in the market for fundraising and alumni association services, and directed their activities towards the same customers (parents and alumni). Note that this is clearly nonresponsive! However, the court also gave weight to plaintiffs’ allegation that “much of the information that Defendants distribute is not, in fact, critical of Plaintiffs.” Nor could defendants’ website disclaimer be ruled sufficient as a matter of law, given the other contents of the website, such as the similar mission statement, “text of the Academy’s alma mater, and pictures of the Academy’s campus.” Plus, there was no showing that defendants used disclaimers in their other challenged activities, such as email and press releases. And plaintiffs alleged incidents of actual confusion.
Nominative fair use: defendants argued that they were only using the marks to identify the plaintiffs as the subject of their criticism. (I don’t see how this works given the name of defendants’ organization.) But “[t]he facts necessary to establish an affirmative defense generally come from outside of the complaint.” The three-part nominative fair use showing (the Third Circuit has its own special version) can only come after a plaintiff shows likely confusion. Further factual development was required.
Dilution: Defendants correctly pointed out that the marks aren’t famous. But the court, despite Twiqbal, accepted well-pleaded facts as true, and plaintiffs alleged that the marks “have been continuously used since 1928, have continuously been used to advertise and promote for Plaintiffs, have been used extensively by the press in connection with Plaintiffs, and are known throughout the nation and world as identifying Plaintiffs.” Comment: That’s not even close. The court doesn’t mention whether plaintiffs pled that their marks were “widely recognized among the general consuming public,” and to contend that they are is entirely implausible. If a court accepts this weak tea at the pleading stage, I sure hope it makes fees available at the summary judgment stage. Hope springs eternal, I guess.
Defendants also argued that their uses were excepted from dilution liability by § 1125(c)(3). But plaintiffs alleged that defendants offered competing alumni services and that there was source confusion, which defeated any exceptions. Note, however, that comparative advertising will generally be by someone in competition with the claimant and it is still categorically protected, and the statute also does not require that the comparative advertising be nonconfusing. Still, to the extent that defendants were using the marks at issue as marks, dilution could apply in the counterfactual world in which the marks were famous, unless it’s a Chewy Vuiton situation in which the reference actually increases the connection between the plaintiff and the marks, which is plausible on these alleged facts (and isn’t even inconsistent with the more persuasive confusion theory!).
False advertising: defendants argued that they weren’t engaged in commercial advertising or promotion, but the court already found that they were engaged in commercial speech. (Note: the conventional test here has three more elements besides that, though one—the requirement of commercial competition—might not properly survive Lexmark.) Anyhow, §43(a)(1)(B) “is broad enough to support, in the context of non-profit fundraising, a claim of false and misleading statements about the services represented by a protected mark.” Birthright v. Birthright, Inc., 827 F.Supp. 1114, 1138 (D.N.J.1993). There’s liability for misrepresentations not only in commercial advertising but also in the “promotion” of services, which plaintiffs alleged.
Posted in dilution, procedure, trademark
Leave a comment
islands in the stream: Netflix v. Verizon
Netflix responds to Verizon’s C&D. For those not keeping track, it started when Netflix started sending error message to certain Verizon customers experiencing playback difficulties, telling them that the Verizon network was slow. Verizon responded angrily, threatening suit and demanding details on which customers received these messages—but the letter was released publicly, which is itself an interesting strategic choice worthy of study. Netflix, unsurprisingly, continues to fight in the court of public opinion, releasing its own response to the C&D while also saying that the messages were part of a “test” scheduled to end soon. Review question: after Lexmark, could there be Lanham Act liability for Netflix—sort of a noncompetitor, sort of a customer—for saying nasty things about Verizon?
![]() |
| Netflix error message indicating Verizon network is congested |
Tough sledding: statements to industry-focused publication can be commercial speech
Skedco, Inc. v. ARC Products, LLC, 2014 WL 2465577, No. 3:13–CV–00696 (D. Or. Jun. 2, 2014)
The parties compete in the market for emergency medical rescue equipment, and are suing over false advertising. Plaintiff’s Sked is “an evacuation sled system designed to quickly evacuate wounded people from confined spaces, from high angles, in technical rescues, and in traditional land-based rescues.” Defendant’s Vertical Lift Rescue Sled (VLR Sled) “is an evacuation device that provides quick transport of a nonambulatory individual in a difficult rescue situation or a confined space.” Here, the court analyzes three of defendant’s false advertising counterclaims.
First, ARC alleged that Skedco claimed that the Sked sled was composed of “Low density E-Z glide polyethylene plastic[,]” commonly referred to as LDPE, that would begin to melt at 450 degrees F to 500 degrees F. In fact, ARC alleged, “publically available technical specification materials demonstrate that LDPE plastic generally starts to melt at the substantially lower temperature of approximately 248 degrees.” ARC attached an example ad flyer, and alleged that Skedco distributed it to third parties, precise identities and dates of distribution to be determined by discovery.
Skedco argued that this pleading flunked Rule 9(b). But ARC gave Skedco enough to prepare an adequate defense: it identified the allegedly false statement, its theory of falsity, and an example ad. Though it didn’t identify a time period or a recipient, or how/if a customer was deceived, the Rule 9(b) standards “may be relaxed where the circumstances of the alleged fraud are peculiarly within the [plaintiff’s] knowledge or are readily obtainable by him.” Skedco can figure out when it distributed its ad, and discovery is required for ARC to know to whom Skedco distributed it. As for deception, ARC sufficiently pled falsity syllogistically, which was enough to put Skedco on notice of the nature of the claim.
Next claim: “Skedco claims its cross-strap Cobra buckles are rated at 3,000 pounds, but this claim is materially misleading because the Sked sled cross-straps are likely to fail where said straps attach to the Sked sled, and that such failure is likely to occur at a significantly lower weight than 3,000 pounds.” ARC challenged similar representations about Skedco’s lift rope strength, claimed to be over 5,000 pounds when, according to ARC, the rope would pull the attachment grommets free from the Sked sled at a lesser weight. These were allegedly misleading claims, not literally false ones. Skedco argued that these claims were inadequately pled because ARC didn’t include any details about actual consumers being misled. But ARC identified the allegedly false statements and the reasons why they were allegedly misleading, and attached a relevant ad. “[T]he court finds it near impossible for defendant to allege which of plaintiff’s customers were actually misled by the advertisement without the benefit of discovery.” There was adequate notice of the claim. ARC also argued falsity by necessary implication (which seems like a valid argument to me, especially given the safety-related nature of the claims), but didn’t plead that; it could seek to amend. (I didn’t realize you needed to plead your precise subtheory of falsity! If you do, I don’t quite understand why the court allowed the misleadingness theory to proceed without allegations about survey evidence or other consumer reaction evidence.)
Finally, ARC challenged representations about Skedco’s loading speed. According to ARC, “Skedco’s Carston ‘Bud’ Calkin made assertions in his capacity as an executive and agent of Skedco in a published interview titled ‘Cleared for Takeoff,’ which appeared in the publication ‘Military Medical & Veterans Affairs Forum’ … that an individual person can have an injured person ready for transport in a Sked sled in a mere 20 seconds and that Calkin [who told the interviewer he was 75] could perform this ‘routinely,’ when in reality it takes significantly longer for an injured person to be loaded into and ready for transport into a Sked sled.” The interview appeared in close proximity to a paid Skedco ad. ARC alleged that in reality it takes substantially longer to load an injured person.
Skedco argued that statements a journalist attributed to a Skedco officer weren’t commercial speech. The journalist might not have been engaging in commercial speech, but “defendant did not bring a claim against the author.” Calkin’s statements highlighted new features of the Sked sled and explained their added benefits to customers. The magazine that published the article claimed to reach a “targeted mailing list” of “the military’s top leadership,” which is to say Skedco’s primary customer. “The court cannot find a purpose behind Calkin’s statements other than to promote his company’s product to potential customers.” Thus, the statements were commercial speech.
They also satisfied the rest of the test for “commercial advertising and promotion”: the parties competed; the statements were about the product; they were meant to influence readers of the article to purchase the Sked sled. Given the targeted audience, Calkin’s statements were disseminated sufficiently to the relevant purchasing public to constitute promotion. Thus, they were actionable under the Lanham Act.




